Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Robinson

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
The Lancet. Oncology|February 28, 2014
4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trialPeter J Hoskin, Amy A Kirkwood, Bilyana Popova, et al.
The Journal of Physical Chemistry. B|October 28, 2025
Cooperative Ligand-Mediated Transitions in Simple MacromoleculesJames L Martin Robinson, Neshat Moslehi, Nikolaos Dramountanis, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative diseaseKevin Harrington, Alain Berrier, Martin Robinson, et al.
Development (Cambridge, England)|December 13, 2019
Neural crest cells bulldoze through the microenvironment using Aquaporin 1 to stabilize filopodiaRebecca McLennan, Mary C McKinney, Jessica M Teddy, et al.
British Journal of Cancer|December 14, 2017
The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcomaLaura Forker, Piers Gaunt, Stefano Sioletic, et al.
BMJ Open|August 9, 2024
Predicting radiotherapy response, Toxicities and quality-of-life related functional outcomes in soft tissue sarcoma of the extremities (PredicT) using dose-volume constraints development: a study protocolRita Simões, Sarah Gulliford, Beatrice Seddon, et al.
British Journal of Cancer|April 21, 2023
Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcomaLaura J Forker, Becky Bibby, Lingjian Yang, et al.
The New England Journal of Medicine|March 24, 2016
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck CancerHisham Mehanna, Wai-Lup Wong, Christopher C McConkey, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2018
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)Christopher M Nutting, James P Morden, Matthew Beasley, et al.
Journal of Open Source Software|May 16, 2023
Chaste: Cancer, Heart and Soft Tissue EnvironmentFergus R Cooper, Ruth E Baker, Miguel O Bernabeu, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Lancet. Oncology|February 28, 2014
4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trialPeter J Hoskin, Amy A Kirkwood, Bilyana Popova, et al.
The Journal of Physical Chemistry. B|October 28, 2025
Cooperative Ligand-Mediated Transitions in Simple MacromoleculesJames L Martin Robinson, Neshat Moslehi, Nikolaos Dramountanis, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative diseaseKevin Harrington, Alain Berrier, Martin Robinson, et al.
Development (Cambridge, England)|December 13, 2019
Neural crest cells bulldoze through the microenvironment using Aquaporin 1 to stabilize filopodiaRebecca McLennan, Mary C McKinney, Jessica M Teddy, et al.
British Journal of Cancer|December 14, 2017
The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcomaLaura Forker, Piers Gaunt, Stefano Sioletic, et al.
BMJ Open|August 9, 2024
Predicting radiotherapy response, Toxicities and quality-of-life related functional outcomes in soft tissue sarcoma of the extremities (PredicT) using dose-volume constraints development: a study protocolRita Simões, Sarah Gulliford, Beatrice Seddon, et al.
British Journal of Cancer|April 21, 2023
Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcomaLaura J Forker, Becky Bibby, Lingjian Yang, et al.
The New England Journal of Medicine|March 24, 2016
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck CancerHisham Mehanna, Wai-Lup Wong, Christopher C McConkey, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2018
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)Christopher M Nutting, James P Morden, Matthew Beasley, et al.
Journal of Open Source Software|May 16, 2023
Chaste: Cancer, Heart and Soft Tissue EnvironmentFergus R Cooper, Ruth E Baker, Miguel O Bernabeu, et al.
Pageof 7